Rakuten Investment Management Inc. Acquires 7,333 Shares of Astera Labs, Inc. $ALAB

Rakuten Investment Management Inc. raised its holdings in Astera Labs, Inc. (NASDAQ:ALAB) by 17.0% during the 3rd quarter, Holdings Channel.com reports. The firm owned 50,571 shares of the company’s stock after acquiring an additional 7,333 shares during the period. Rakuten Investment Management Inc.’s holdings in Astera Labs were worth $18,096,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in ALAB. BlackRock Inc. purchased a new stake in Astera Labs in the 2nd quarter worth approximately $6,609,581,000. Atreides Management LP increased its holdings in shares of Astera Labs by 108.9% during the 1st quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock valued at $368,890,000 after purchasing an additional 1,754,593 shares in the last quarter. Van ECK Associates Corp increased its holdings in shares of Astera Labs by 20.0% during the 2nd quarter. Van ECK Associates Corp now owns 2,237,961 shares of the company’s stock valued at $1,080,980,000 after purchasing an additional 373,545 shares in the last quarter. Bank of America Corp DE purchased a new position in shares of Astera Labs during the 2nd quarter valued at approximately $1,061,791,000. Finally, Amundi lifted its stake in shares of Astera Labs by 77.9% in the 1st quarter. Amundi now owns 1,880,830 shares of the company’s stock valued at $206,139,000 after purchasing an additional 823,477 shares during the period. 60.47% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Astera Labs

In other news, General Counsel Philip Mazzara sold 6,801 shares of the stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $340.50, for a total value of $2,315,740.50. Following the completion of the sale, the general counsel directly owned 96,542 shares in the company, valued at $32,872,551. This represents a 6.58% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Stefan Dyckerhoff sold 8,994 shares of the firm’s stock in a transaction that occurred on Wednesday, October 7th. The stock was sold at an average price of $376.06, for a total transaction of $3,382,283.64. Following the completion of the transaction, the director directly owned 2,648 shares in the company, valued at $995,806.88. This trade represents a 77.25% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 396,059 shares of company stock valued at $123,408,470. 10.40% of the stock is owned by company insiders.

Astera Labs Price Performance

Shares of Astera Labs stock opened at $223.27 on Thursday. The business has a 50 day simple moving average of $304.94 and a two-hundred day simple moving average of $255.78. Astera Labs, Inc. has a 12 month low of $97.89 and a 12 month high of $499.48. The stock has a market capitalization of $38.73 billion, a P/E ratio of 88.95 and a beta of 3.85.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings results on Tuesday, November 3rd. The company reported $1.32 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.19 by $0.13. Astera Labs had a return on equity of 27.30% and a net margin of 29.64%. The firm had revenue of $584.90 million for the quarter, compared to analyst estimates of $550.78 million. During the same period in the previous year, the company posted $0.49 earnings per share. The business’s revenue was up 153.6% on a year-over-year basis. As a group, research analysts anticipate that Astera Labs, Inc. will post 2.71 EPS for the current fiscal year.

Key Stories Impacting Astera Labs

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Q3 earnings of $1.32 per share beat the $1.19 consensus, while revenue of $584.9 million exceeded estimates and rose 153.6% year over year. Scorpio switches, including the X-Series, were a key growth driver. Article: Astera Labs Q3 Earnings and Revenues Beat Estimates
• Positive Sentiment: Management forecast Q4 revenue of $730 million to $750 million, citing AI connectivity demand. Expansion into optical connectivity, memory and rack-scale AI systems may provide additional growth opportunities. Article: ALAB Q3 Earnings Call Highlights Scorpio Ramp and New Growth Engines
• Neutral Sentiment: Analyst opinions were mixed: Northland upgraded ALAB to Outperform and Morgan Stanley raised its price target, while several firms lowered targets; RBC maintained an Outperform rating. Article: Northland Securities stock recommendations
• Negative Sentiment: Shares fell despite the earnings beat, suggesting results and guidance may not have been enough to satisfy expectations. Analysts flagged a premium valuation, rising costs, reliance on a limited number of customers and competition—particularly Marvell’s optical push—as risks to future growth. Article: Astera Labs Stock Falls Despite Strong Earnings. Its Growth Story Is Intact.

Analysts Set New Price Targets

A number of research analysts have weighed in on the stock. Morgan Stanley lifted their price objective on shares of Astera Labs from $382.00 to $389.00 and gave the company an “overweight” rating in a report on Wednesday. Roth Capital reissued a “buy” rating and set a $450.00 target price on shares of Astera Labs in a research note on Wednesday, August 5th. Royal Bank Of Canada dropped their target price on Astera Labs from $500.00 to $400.00 and set an “outperform” rating on the stock in a research report on Wednesday. Citigroup lowered Astera Labs from a “buy” rating to a “hold” rating in a research note on Friday, October 9th. Finally, Barclays lifted their price target on Astera Labs from $200.00 to $325.00 and gave the company an “equal weight” rating in a research note on Monday, July 20th. Twelve analysts have rated the stock with a Buy rating and ten have given a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $318.00.

Astera Labs Profile

Astera Labs, Inc is a semiconductor and connectivity solutions company that develops hardware and software for data centers, cloud computing, and artificial intelligence infrastructure. Its products are designed to help move data between processors, memory, storage, and networking components while addressing bandwidth, latency, and system-management requirements.

The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) Smart Retimers, Taurus Ethernet Smart Cable Modules, Scorpio Smart Fabric Switches, and Leo CXL Memory Connectivity Controllers.